The CHARM program consisted of 3 component trials, each comparing candesartan with placebo in a distinct population of patients with symptomatic heart failure [9]: CHARM-Alternative: patients with ...
UVA Health researchers have developed a powerful new risk assessment tool for predicting outcomes in heart failure patients. The researchers have made the tool publicly available for free to ...
Please provide your email address to receive an email when new articles are posted on . CAD was significantly prognostic of all-cause mortality in patients with heart failure. Mortality risk was ...
Late-stage failure of the left side of the heart is an often-fatal condition affecting hundreds of thousands of people in the U.S. alone. A mechanical heart pump can be a lifesaving intervention for ...
Many people have no idea what their risk is—until it's too late.
Cardiosense Presents New Clinical Analysis of SEISMIC-HF I Data on AI-Enabled Volume Assessment in Heart Failure at the Transcatheter Cardiovascular Therapeutics (TCT) 2025 Scientific Symposium ...
The powerful new AI tool can predict heart failure outcomes in specific patients, helping doctors improve care. UVA Health researchers have developed a powerful new risk assessment tool for predicting ...
News Medical on MSN
Physical function metrics improve mortality prediction in elderly heart failure patients
Current models of mortality risk after heart failure (HF) rely primarily on cardiac-specific clinical variables and may underestimate risk in elderly East Asian patients. Researchers from Japan used ...
The OHSU-led study shows reduced heart failure-related hospitalizations, deaths in high-risk individuals A new OHSU-led analysis found ...
Panelists discuss how heart failure creates a massive economic burden of approximately $30 billion annually (expected to reach $70 billion to $80 billion by 2030), driven by hospitalizations, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results